BSE Live
Jan 22, 16:01Prev. Close
1369.55
Open Price
1370.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 22, 15:59Prev. Close
1369.60
Open Price
1381.20
Bid Price (Qty.)
1370.40 (49)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Cipla (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 5,657.85 | 5,295.33 | 4,293.95 | 3,656.92 | 3,103.62 | |
| Less: Excise/Sevice Tax/Other Levies | 52.16 | 61.04 | 90.66 | 94.93 | 122.27 | |
| Revenue From Operations [Net] | 5,605.69 | 5,234.29 | 4,203.29 | 3,561.99 | 2,981.35 | |
| Total Operating Revenues | 5,605.69 | 5,234.29 | 4,203.29 | 3,561.99 | 2,981.35 | |
| Other Income | 30.71 | -139.51 | 134.92 | 100.68 | 112.20 | |
| Total Revenue | 5,636.40 | 5,094.78 | 4,338.21 | 3,662.67 | 3,093.55 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2,158.03 | 2,016.78 | 1,800.44 | 1,443.27 | 1,307.59 | |
| Purchase Of Stock-In Trade | 621.66 | 588.04 | 458.94 | 398.33 | 319.60 | |
| Operating And Direct Expenses | 259.67 | 262.65 | 233.90 | 186.47 | 170.63 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -184.09 | -113.55 | -41.37 | 30.73 | -94.35 | |
| Employee Benefit Expenses | 318.87 | 271.33 | 255.45 | 184.59 | 150.76 | |
| Finance Costs | 22.95 | 32.94 | 11.69 | 6.95 | 11.42 | |
| Depreciation And Amortisation Expenses | 165.25 | 151.79 | 130.68 | 103.37 | 80.18 | |
| Other Expenses | 1,055.97 | 983.49 | 650.12 | 500.98 | 437.88 | |
| Total Expenses | 4,418.31 | 4,193.47 | 3,499.85 | 2,854.69 | 2,383.71 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,218.09 | 901.31 | 838.36 | 807.98 | 709.84 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 1,218.09 | 901.31 | 838.36 | 807.98 | 709.84 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 228.50 | 101.00 | 94.00 | 121.75 | 89.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 15.00 | 15.00 | 36.50 | 14.70 | 9.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 243.50 | 124.50 | 136.93 | 139.95 | 102.20 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 974.59 | 776.81 | 701.43 | 668.03 | 607.64 | |
| Profit/Loss From Continuing Operations | 1,081.49 | 776.81 | 701.43 | 668.03 | 607.64 | |
| Profit/Loss For The Period | 1,081.49 | 776.81 | 701.43 | 668.03 | 607.64 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 13.47 | 9.99 | 9.02 | 8.59 | 20.26 | |
| Diluted EPS (Rs.) | 13.47 | 9.99 | 9.02 | 8.59 | 20.26 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 927.26 | 845.45 | 770.23 | 594.34 | 499.82 | |
| Indigenous Raw Materials | 1,187.31 | 1,137.43 | 978.85 | 815.03 | 772.49 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 160.58 | 155.46 | 155.46 | 155.46 | 155.46 | |
| Tax On Dividend | 26.67 | 26.42 | 26.42 | 26.42 | 21.80 | |
| Equity Dividend Rate (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
08.01.2026
07.01.2026
Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site
17.12.2025
11.12.2025
10.11.2025
Cipla Standalone September 2025 Net Sales at Rs 5,225.72 crore, up 9.44% Y-o-Y
03.11.2025
Cipla Consolidated September 2025 Net Sales at Rs 7,589.44 crore, up 7.64% Y-o-Y
25.07.2025
Cipla Standalone June 2025 Net Sales at Rs 5,046.17 crore, up 12.11% Y-o-Y
25.07.2025
Cipla Consolidated June 2025 Net Sales at Rs 6,957.47 crore, up 3.94% Y-o-Y
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
09.05.2024
17.04.2024
Cipla Q4 PAT may dip 24.9% YoY to Rs 869.4 cr: ICICI Securities
12.07.2023
28.01.2025
30.10.2024
Multiple near-term challenges may hijack Cipla's growth trajectory
13.05.2024
06.11.2018
Cipla down 5% on poor Q2, tough guidance ahead; Citi, HSBC downgrade ratings